Related Experiment Videos
Effect of solution phase composition on the interaction between aqueous model solutes and polymeric container
1Baxter Healthcare Corporation, William B. Graham Science Center, Round Lake, Illinois 60073.
Pharmaceutical Research
|June 1, 1991
Summary
Polyolefin laminate polymer interactions with intravenous solutions were studied. Octanol-water partition coefficients predicted interactions, with pH being key for ionic solutes, suggesting water as a model solvent for container compatibility testing.
Area of Science:
- Materials Science
- Pharmaceutical Science
- Analytical Chemistry
Background:
- Polyolefin laminate polymers are used in intravenous (IV) product packaging.
- Understanding container-solution interactions is crucial for IV product stability and safety.
- Marker solute interactions can predict potential issues with IV formulations.
Purpose of the Study:
- To investigate the interaction between polyolefin laminate polymers and various IV solutions.
- To determine factors influencing these interactions.
- To identify suitable model solvents for container compatibility testing.
Main Methods:
- Studied interactions of marker solutes with polyolefin laminate polymer in diverse solutions.
- Included sodium chloride/dextrose mixtures and actual IV products (e.g., Lactated Ringer's, Dianeal, Travasol).
- Correlated interaction properties with solute octanol-water partition coefficient and solution composition (pH).
Main Results:
- Container/solution interaction correlated with solute octanol-water partition coefficient.
- Nonionic solute interactions were independent of solution composition.
- Solution pH significantly influenced ionic solute interactions by affecting speciation.
Conclusions:
- The octanol-water partition coefficient is a key predictor of polyolefin laminate polymer-solute interactions.
- Solution pH is critical for ionic solutes, impacting their interaction with the polymer.
- Water or weak buffer solutions are recommended as appropriate model solvents for IV container compatibility evaluations.